Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Franklin
E C Rackow

JAMA

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
JAMA|July 24, 1991
Pathophysiology and treatment of septic shockE C Rackow, M E Astiz
JAMA|August 5, 1988
'Lactate washout' following circulatory arrestJ A Leavy, M H Weil, E C Rackow
JAMA|July 3, 1991
Long-term survival of patients with AIDS, Pneumocystis carinii pneumonia, and respiratory failureY Friedman, C Franklin, S Freels, et al.
JAMA|June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study GroupC J Fisher, J F Dhainaut, S M Opal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
JAMA|July 24, 1991
Pathophysiology and treatment of septic shockE C Rackow, M E Astiz
JAMA|August 5, 1988
'Lactate washout' following circulatory arrestJ A Leavy, M H Weil, E C Rackow
JAMA|July 3, 1991
Long-term survival of patients with AIDS, Pneumocystis carinii pneumonia, and respiratory failureY Friedman, C Franklin, S Freels, et al.
JAMA|June 15, 1994
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study GroupC J Fisher, J F Dhainaut, S M Opal, et al.
Pageof 1